Working Zachary M, Frederiksen Hunter, Drew Alex, Loc-Carrillo Catherine, Kubiak Erik N
University of Utah Department of Orthopaedic Surgery, Salt Lake City, UT, USA.
University of Utah Undergraduate Program, Salt Lake City, UT, USA.
Injury. 2017 Jul;48(7):1459-1465. doi: 10.1016/j.injury.2017.04.040. Epub 2017 Apr 21.
Locally delivered, crystalline vancomycin has been suggested as a potential prophylactic measure against the development of deep and superficial surgical site infection. Clinical expectations regarding the duration and peak of drug concentration in local tissues following administration are unknown. Our goal was to develop concentration vs time curves for locally administered vancomycin powder in a high-energy, open femur fracture rat model in local tissues and to compare that data to two well performed similar, systemic administration studies.
After approval for animal research, 24 adult Sprague-Dawley rats sustained closed, midshaft femoral fracture under anesthesia. Fractures were caused via blunt guillotine with 750g metal rod dropped 50cm. Injured hindlimbs were surgically opened at fracture to simulate open injury and stabilized using 0.054 Kirschner wires. Vancomycin powder was administered using weight-based protocol (goal: 25mg/kg). Rats were sacrificed in groups of 4 at 4, 8, 24, 48, 72, 96h. Samples harvested included rat-tail venous blood prior to sacrifice, and femoral bone and anterior thigh soft-tissue were harvested post-mortem. High Performance Liquid Chromatography (HPLC) was performed on all samples.
Concentration vs. time curves demonstrated that the surrounding soft-tissues demonstrated highest maximum concentration (1.5mg vancomycin/g muscle). Bone reached maximum average of 199μg vancomycin/g femur: approximately 13% of maximal soft-tissue absorption. Plasma reached maximum concentration of 1.8μg/mL plasma. All peaks at t=4h. Within 48h, average muscle vancomycin concentration dropped to 3μg/g muscle (0.2% maximum muscle concentration) and the average bone concentration dropped to 1.9μg/g femur (0.9% maximum bone concentration). Vancomycin was undetectable on all samples at 96h. Comparison to classical animal studies suggest local delivery to bone exceeds that of IV dosing for approximately 48h and may peak near concentrations of 10 multiples.
Locally administered vancomycin provides drug delivery in excess of IV dosing for approximately 48h after intervention. Exponential decay demonstrates rapid removal of drug to near undetectable levels in bone, plasma, and local soft tissue thereafter in a rat model. Local delivery may generate concentrations exceeding that achievable by steady state systemic dosing for 48h.
局部应用的结晶万古霉素已被提议作为预防深部和浅表手术部位感染的一种潜在措施。给药后局部组织中药物浓度的持续时间和峰值的临床预期尚不清楚。我们的目标是在高能开放性股骨骨折大鼠模型中,绘制局部应用万古霉素粉末在局部组织中的浓度-时间曲线,并将该数据与另外两项执行良好的类似全身给药研究进行比较。
在获得动物研究批准后,24只成年Sprague-Dawley大鼠在麻醉下发生闭合性股骨干骨折。骨折是通过用750g金属棒从50cm高处落下的钝性断头台造成的。受伤的后肢在骨折处手术切开以模拟开放性损伤,并用0.054的克氏针固定。万古霉素粉末按照基于体重的方案给药(目标:25mg/kg)。在4、8、24、48、72、96小时时,将大鼠按每组4只处死。采集的样本包括处死前的大鼠尾静脉血,以及死后采集的股骨和大腿前部软组织。对所有样本进行高效液相色谱(HPLC)分析。
浓度-时间曲线表明,周围软组织显示出最高的最大浓度(1.5mg万古霉素/克肌肉)。骨骼达到的最大平均浓度为199μg万古霉素/克股骨:约为最大软组织吸收量的13%。血浆达到的最大浓度为1.8μg/mL血浆。所有峰值均出现在t = 4小时。在48小时内,肌肉中万古霉素的平均浓度降至3μg/克肌肉(最大肌肉浓度的0.2%),骨骼中的平均浓度降至1.9μg/克股骨(最大骨骼浓度的0.9%)。在96小时时,所有样本中均未检测到万古霉素。与经典动物研究的比较表明,局部给药至骨骼的药物浓度超过静脉给药约48小时,且峰值浓度可能接近静脉给药浓度的10倍。
局部应用万古霉素在干预后约48小时内提供的药物递送量超过静脉给药。指数衰减表明药物在大鼠模型中迅速清除至骨骼、血浆和局部软组织中几乎检测不到的水平。局部给药可能产生超过稳态全身给药所能达到的浓度,并持续48小时。